Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 180 member A (FAM180A) is a protein-coding gene found in humans and other mammals, initially described based on its sequence homology rather than a defined biological function. Current evidence suggests the encoded protein is likely secreted and localized to the extracellular region[1][5]. FAM180A has no well-characterized molecular function, pathway, or disease mechanism, and neither pharmacological modulators nor clinical relevance as a drug target have been described. There is no evidence that it acts as a canonical therapeutic target such as a receptor, enzyme, transporter, or transcription factor. Research indicates some sequence conservation and there are limited associations with bone-related sarcomas, but functional studies are lacking, and its role—if any—in pathophysiology or therapy remains undefined[5][3][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 180 member A (FAM180A).